Indiana Compounder Indicted on Conspiracy, Drug Potency

Drug Industry Daily
A A
Pharmakon Pharmaceuticals executives routinely sent drugs to hospitals without waiting for test results confirming the potency of the drugs matched their labels, and when results showed the strength was often nearly double what it should have been, covered up the error and lied to FDA investigators rather than notifying the FDA or customers, according to a 10-count federal indictment.

To View This Article:

Login

Subscribe To Drug Industry Daily